Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Allen

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Molecular Therapy. Advances|May 15, 2026
Manufacture of adeno-associated virus vectors by a novel human-derived cell line HAT and comprehensive evaluation of the vectorsYasuo Tsunaka, Mitsuko Fukuhara, Saki Shimojo, et al.
Plos One|February 1, 2017
Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus MacaquesLark L Coffey, Patricia A Pesavento, Rebekah I Keesler, et al.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Molecular Therapy. Advances|May 15, 2026
Manufacture of adeno-associated virus vectors by a novel human-derived cell line HAT and comprehensive evaluation of the vectorsYasuo Tsunaka, Mitsuko Fukuhara, Saki Shimojo, et al.
Plos One|February 1, 2017
Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus MacaquesLark L Coffey, Patricia A Pesavento, Rebekah I Keesler, et al.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 13